The reaction of activated derivatives of clavulanic acid with substituted amidoethenyl thiolates to give 9-(2-amidoethenylthio)-9-deoxy derivatives is described; the antibacterial/ synergistic and /3-lactamase inhibitory activities of the thioethers and their corresponding sulfoxides and sulfones are compared.
Clavulanic acid (1) is a naturally occurring /3-lactamase inhibitor which acts as a synergist for penicillins and cephalosporins, increasing their activity against /3-lactamase producing strains of bacteria such as Escherichia coli, Klebsiella aerogenes and Staphylococcus aureusD. Since its discovery there has been much interest in preparing analogues and derivatives^of this microbial metabolite in the hope of finding new compounds with enhanced biological activity. As part of a program designed to prepare new derivatives of 1 we have prepared a number of substituted amidoethenylthio derivatives and their corresponding surfoxides and sulfones.
Chemi stry
The syntheses of 9-(2-amidoethenylthio)-9-deoxy derivatives of clavulanic acid (1) are outlined in Scheme 1 and the compounds prepared are summarised in Table 1 . Reaction of activated derivatives of clavulanic acid, such as the chloride (3)3) and the dichloroacetate (4)4), with the appropriate thiolates (13a~13f) afforded thioethers (5a~5f) as mixtures of Z and E isomers, which were separated by columnchromatography. Oxidation of the thioethers with 1.1 equivalents of ra-chloroperoxybenzoic acid gave the sulfoxides (6a and 6b) whilst 2.2 equivalents of ra-chloroperoxybenzoic acid provided the sulfones (7a, 7b, 7d and If). The^-nitrobenzyl protecting group of the thioethers (5a~5f) was removed by iron-ammonium chloride dissolving metal reduction. This method failed in the case of the sulfoxides (6a and 6b) and the removal of the protecting group was accomplished by hydrogenolysis over palladium on charcoal in tetrahydrofuran solution. The sulfones (7a? 7b, Id and 7f) were also deprotected using iron-am-PNB =/? -Nitrobenzyl Scheme 1. Preparation of 9-(2-amidoethenylthio)-9-deoxy clavulanic acid derivatives.
moniumchloride dissolving metal reduction. The products were isolated as their lithium or sodium salts by neutralising an aqueous solution of the free acids (8a~8f, 9a, 9b, 10a, 10b, lOd and lOf) with 0.1 maqueous lithium carbonate or 0.1 msodium bicarbonate and freeze-drying the aqueous solution and were sufficiently pure for biological testing. Thiolate (13a) was prepared by cleavage of 2,3-dihydro-4i/-(l ,4-thiazm-3-one) (14) using sodium in liquid ammonia5). A more general and convenient route to the thiolates (13a~13f) is outlined in Scheme 26). Reaction of bromoacetaldehyde diethyl acetal with ethanethiol and sodium ethoxide in ethanol gave l,l-diethoxy-2-ethylthioethane (ll), which on acid catalysed (^-toluene sulfonic acid) reaction with the appropriate amide gave the unsaturated sulfides (12a~12f) as mixtures of Z and E isomers (compounds 12c and 12d could be separated by column chromatography at this stage). Cleavage of the sulfides with sodium in liquid ammoniagave the sodium thiolates (13a1 3f).
The numbering follows that used in penicillins, shown in 1.
Biology
The biological activities of these derivatives are given in Table 2 . All derivatives showed poor inhibitory activity against the cephalosporinase of Enterobacter cloacae, but all were potent inhibitors of TEM-1and staphylococcal /5-lactamases, with activity similar to that of clavulanic acid.
All were equally effective synergists of amoxycillin in vitro against $. aureus, but differences could be seen against a TEM-1producing E. coli presumably reflecting different rates of penetration into the bacterial periplasm. The four sulfones (10a, 10b, lOd and lOf) were 2-to 4-fold more active than their corresponding sulfides (8a, 8b, 8d and 8f) with the two sulfoxides giving a somewhat mixed spectrum of activity; the E isomer (9b) was as active as the sulfone analogue (10b) while the Z isomer (9a) wasmuchless active. In vivo, the differences in potency were muchclearer. The sulfones were once again more potent than the corresponding sulfoxides or sulfides, and the E isomers (8b, 8d, 8f, 9b and 10b) were more active than the corresponding Z isomers (8a, 8c, 8e, 9a and 10a). In two cases (8a vs. 8b and 9a vs. 9b), the relative activities of the E and Z isomers in vitro were not reflected in vivo, perhaps due to differing distribution characteristics or metabolic stability of the isomer pairs. Optimal activity was seen with the Is-acetamido derivative (10b).
Exp erimental /3-Lactamase inhibition studies were carried out on isolated enzyme preparations by spectrophotometric monitoring of hydrolysis of a standard (ampicillin) in the presence and absence of a #-lactamase inhibitor70.
MICdeterminations were carried out in Microtiter plates by serial dilution of amoxycillin (Amox) in broth, followed by addition of inhibitor (1 /*g/ml) and organism (approx 2x 106 cfu/ml), as described previously1}.
The 50%-curative dose (CD50) determinations were performed in mice. The organism (E. coli E96) was suspended in 3 % hog gastric mucin+1 % carboxymethyl cellulose at 100 xLD50, and 0.5 ml of suspension was injected ip into groups of five mice. Compoundswere administered subcutaneously at 2 mg/kg with varying doses of amoxycillin at 1 and 5 hours post infection, and survivors were recorded over a 4-day period. The CD50of amoxycillin in the presence of 2 mg/kg inhibitor was calculated by log probit analysis, and relative potencies were defined as (CD50 Amox+2mg/kg clavulanic acid)/(CD50 Amox+2mg/kg derivative). This test had a high level of reproducibility with the amoxycillin/clavulanic acid CD50of 30±13 mg/kg. UVspectra were recorded on a Pye-Unicam SP 8000 or a Perkin-Elmer 554 spectr©photometer. Unless otherwise stated IR spectra were recorded for solutions in CHC13on a Perkin-Elmer 197 or 457 machine. *H NMR spectra were recorded at 60 MHzon a Varian EM360 and at 90 MHzon a Perkin-Elmer R32 instrument for solutions in CDC13with TMSas internal standard unless otherwise stated. The purity of all compounds was tested by TLC on Merck precoated Silica gel 60 F254 plates.
Preparative chromatography was carried out on columns of MerckSilica gel 60 (230~400 mesh ASTM)with eluants as stated using the slightly increased pressure provided by a Medcalf Hy-flo pump. MP's were determined with a Kofler hot-stage apparatus and are uncorrected. Compounds24), 33), 44) , 13a and 145) were prepared by published procedures and the syntheses of the amidoethenyl thiolates (13a~13f) may be found in the patent literature6).
The following general synthetic procedures illustrate the methods used to prepare 9-(2-amidoethenylthio)-9-deoxy derivatives of clavulanic acid and further examples are described in ref 6 .
General Procedure for the Preparation of Thioethers (5a~5f) The preparation of thioethers (5a and 5b) was typical of the method used. A 1 : 1 mixture of sodium Z-2-acetamidovinylthiolate and sodium i>2-acetamidovinylthiolate (13a and 13b) (4.15 g, 0.03 mol) was added to a stirred, ice-cooled solution ofi?-nitrobenzyl 9-chloro-9-deoxyclavulanate (3) (6.78 g, 0.02 mol) in dry DMF(200 ml) and stirring continued for 45 minutes. EtOAc (400 ml) was added and the mixture washed with water (3 x 300 ml), dried over magnesium sulfate and evaporated. Chromatography of the residue using EtOAc-petrol (bp 60~80°C) as eluent gave as the less polar product (1.33 g, 16%) the Z isomer (5a) Alternative Preparation of Thioether (5a) Sodium Z-2-acetamidovinylthiolate (13a) (0.35 g, 1.77 mmol as a 1 : 1 mixture with NaCl) was added to a stirred, ice-cooled solution of 3 (0.63 g, 1.78 mmol) in dry DMF(20 ml) and stirring continued for 30 minutes. EtOAc (100 ml) was added and the mixture washed with water (2x 100 ml), dried over anhydrousmagnesiumsulfate and evaporated. Theresidue was chromatographedusing EtOAc-petrol (bp 60~80°C) as eluent to give, as a pale yellow foam (0.40 g, 52%), a compound identical in all respects to the Z isomer (5a) described above.
Preparation of the Sulfoxides (6a and 6b) The ester (5a) (0.25 g) was dissolved in dichloromethane (20 ml), ice-cooled with stirring and treated dropwise over 5 minutes with a solution of m-chloroperoxybenzoic acid (0.10 g) in dichloromethane (5 ml). After stirring for 30 minutes the solution was washed with 1 m sodium bicarbonate (2 x20 ml) and water (20 ml), dried over MgSO4 and evaporated. Chromatography of the residue on silica gel using EtOAc -petrol (bp 60~80°C) as eluent gave the sulfoxide (6a) (0.12 g, 46%) as a colourless foam: employing the E isomer (5b) provided the E sulfoxide (6b) as a colourless foam (69 %).
General Procedure for the Preparation of Sulfones (7a, 7b, 7d and 7f) The preparation of the sulfone (7a) was typical. A stirred, ice-cooled solution of the ester (5a) (0.60 g) in dichloromethane (50 ml) was treated dropwise over 10 minutes with a solution of ra-chloroperoxybenzoic acid (0.50 g) in dichloromethane (10 ml). The mixture was stirred at 0~5°C for 2 hours, washed with 1 maqueous sodium bicarbonate solution (2x50 ml) and water (50 ml), dried over MgSO4and evaporated. The residue was chromatographed on silica gel using EtOAc -petrol (bp 60~80°C) as eluent to give the sulfone (7a) as a Similarly, thio ethers (5b, 5d and 5f) were converted into their corresponding sulfones (7b, 7d and 7f). General Procedure for De-esterification of Thioethers (5a~5f) with Iron-ammonium Chloride and Sulfones (7a, 7b, 7d and 7f)
The de-esterification of 5a was typical. A solution of the ester (5a) (0.143 g, 0.33 mmol) was dissolved in THF (14 ml) with stirring, icecooled and treated with 1 m aqueous ammonium chloride solution (4 ml) and iron powder (0.5 g). After 20 minutes a further 0.3 ml of 1 m aqueous ammoniumchloride solution and 0.5 g of iron powder were added and stirring continued for 45 minutes. EtOAc (20 ml) was added and H2S bubbled through the mixture for 10 minutes with ice-cooling. The mixture was filtered through Celite and the residue washed with water (20 ml). The aqueous layer of the filtrate (including washings) was saturated with sodium chloride, acidified with 1 n HC1to pH 2.5 and separated from the organic layer. The aqueous layer was further extracted with EtOAc (2 x 20 ml) and the combined EtOAc extracts dried over MgSO4. After filtration the EtOAc was extracted with pH 7 phosphate buffer (3 x20 ml). The combined aqueous extracts were saturated with sodium chloride, acidified to pH 2.5 with 1 n HC1and extracted with EtOAc (3 x20 ml). The EtOAc extracts were dried over MgSO4, evaporated, and the residue quickly taken up in THF (10 ml) and water (10 ml). This solution was brought to pH 7 by addition of 0.1 m lithium carbonate solution, washed with ether (10 ml) and freeze-dried to give the lithium salt (8a) (0.054 g, 54%) as a pale yellow solid: M2D°+49.5°(c 0. 8 Hz, =C/fNH). Thioethers (5b-5f) and sulfones (7a, 7b, 7d and 7f) were deprotected using analogous procedures.
De-esterification of Sulfoxides (6a and 6b) A solution of the ester (6a) (0.138 g) in THF (50 ml) was added to a prehydrogenated suspension of 10% palladium on charcoal (0.20 g) in THF (50 ml). Hydrogenation at 1 atmosphere was continued for 2 hours, the suspension filtered through Celite and the filtrate evaporated to 5 ml. Water (20 ml) was added followed by a solution of 0.1 m lithium carbonate (1.53 ml). The solution was washed with ether (3 x20 ml), adjusted to pH 7 with 0.5 n HC1 and freeze-dried to give the lithium salt of9a as a yellow solid (0.07 g, 71 %): M2D°+36.8°(c 0.8, DMSO); IR vmax (KBr) cm"1 1783, 1685, 1620; UV ;Sfi nm (e) 236 (10,400); *H NMR (90 MHz, D2O) d 2.06 (3H, s, COCH3), 3.04 (1H, d, /=17.5Hz, 6/3-CH), 3.52 (1H, dd, /=17.5 and 2.5Hz, 6a-CH), 3.75 (2H, brd, /-8 Hz, 9-CH2), 5.55 (1H, d, /=8 Hz, SOCH-), 5.69 (1H, brs, 5-CH), 7.34 (1H, d, J=B Hz, =C#NH), 8-CH and 3-CH obscured by DOH. An analogous procedure using the E isomer (6b) gave the E sulfoxide lithium salt 9b.
